Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Anderson Robert Eugene Jr, holds the title of Director at FILANA THERAPEUTICS, INC..
On 2026-11-18, the insider transacted 19,000 shares.The shares were transacted at a weighted average price of $0.52 per share, resulting in a total market-relevant value of $10K.
Anderson Robert Eugene Jr (Director) bought $10K of $FLNA
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.